Document Detail

Population pharmacokinetic modeling of tramadol and its O-desmethyl metabolite in plasma and breast milk.
MedLine Citation:
PMID:  21394525     Owner:  NLM     Status:  Publisher    
PURPOSE: The aim of this investigation was to demonstrate that nonlinear mixed-effects population pharmacokinetic (PK) modeling can be used to evaluate data from studies of drug transport/excretion into human milk and hence to estimate infant exposure. METHODS: A sparse dataset from a previously published study of the use of oral tramadol for post-cesarean pain management in 75 lactating women was used. Milk and plasma samples were collected during days 2-4 of lactation, and tramadol and O-desmethyltramadol (ODT) concentration measurements in these samples were available. Absolute infant dose was obtained from the concentration measurements and estimated milk volume ingested, and expressed in micrograms per kilogram per day. Relative infant dose was calculated as a percentage of the absolute infant dose divided by the maternal dose (μg/kg/day). Nonlinear mixed-effects modeling was used to fit a population PK model to the data. RESULTS: The disposition of tramadol and ODT in plasma and the transition of these substances into milk were characterized by a five-compartment population PK mixture model with first-order absorption. The polymorphic ODT formation clearance in the plasma compartment was able to be characterized in both CYP2D6-poor and -extensive metabolizers. Milk creamatocrit was a significant covariate in ODT transfer between the plasma and milk compartments. The estimated relative infant doses in extensive and poor metabolizers, respectively, were 2.16 ± 0.57 and 2.60 ± 0.57% for tramadol, and 0.93 ± .20 and 0.47 ± 0.10% for ODT. CONCLUSIONS: This study demonstrates that a population PK approach with sparse sampling of analytes in milk and plasma can yield quality information about the transfer process and that it also can be used to estimate the extent of infant exposure to maternal drugs via milk.
Sam Salman; Sherwin K B Sy; Kenneth F Ilett; Madhu Page-Sharp; Michael J Paech
Related Documents :
10797425 - Oeis complex--a population study.
10740205 - Dandy-walker malformation: prenatal diagnosis and outcome.
10466595 - A population-based study of congenital diaphragmatic hernia: impact of associated anoma...
2359095 - Consanguinity and its effect on fetal growth and development: a south indian study.
9476875 - Using low-frequency oscillation to detect bronchodilator responsiveness in infants.
3956315 - Prematurity stereotyping: effects on mother-infant interaction.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-3-11
Journal Detail:
Title:  European journal of clinical pharmacology     Volume:  -     ISSN:  1432-1041     ISO Abbreviation:  -     Publication Date:  2011 Mar 
Date Detail:
Created Date:  2011-3-11     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  1256165     Medline TA:  Eur J Clin Pharmacol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
School of Medicine and Pharmacology, University of Western Australia, Crawley, Australia.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Effect of acute and chronic zofenopril administration on cardiac gene expression.
Next Document:  Performance of different data sources in identifying adverse drug events in hospitalized patients.